
ファーマの未来はコラボレーションにある
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.
AI-based methods are offering superhuman image enhancement. But their medical applications are not without risk – unless, that is, you consider a hybrid approach.
この度のケンブリッジコンサルタンツのブランドリニューアルにより、The Engineとの関係がより強固になりました。The Engineは、MIT(マサチューセッツ工科大学)によって設立されたベンチャーキャピタルであり、気候変動、健康といった長期での社会的課題解決を目指すアーリーステージの「タフテック」企業を支援しています。戦略的パートナーとして、士気が高く、使命感に溢れているスタートアップの起業家と関わることは、弊社にとって大きな喜びです。
Dr Ashwini Sharan and Cambridge Consultants provoked debate with a film, ‘A day in the life of a Parkinson’s patient in 2030’, which imagined seamless therapy enabled by smart active implants, surgical robotics, digital connectivity and AI
Should we be designing systems that autonomously control both accuracy and precision for the best outcome of the patient? Andy Savarese explores the questions and looks ahead as the role of surgical robotics evolves.